{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:40:27Z","timestamp":1782603627564,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/rmed.2002.1381","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T09:20:15Z","timestamp":1042104015000},"page":"872-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials"],"prefix":"10.1053","volume":"96","author":[{"given":"D.C.S.","family":"HUTCHISON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"COOPER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/rmed.2002.1381_RF1","first-page":"1","article-title":"Studies in alpha1-antitrypsin deficiency","volume":"177","author":"Eriksson","year":"1965","journal-title":"Acta Med Scand"},{"key":"10.1053\/rmed.2002.1381_RF2","first-page":"176","article-title":"Alpha1-antitrypsin and its deficiency","volume":"110","author":"Kueppers","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2002.1381_RF3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0007-0971(83)90002-5","article-title":"Alpha1\u2013antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: a survey by the British Thoracic Association","volume":"77","author":"Tobin","year":"1983","journal-title":"Br J Dis Chest"},{"key":"10.1053\/rmed.2002.1381_RF4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0954-6111(98)90278-5","article-title":"\u03b11-Antitrypsin deficiency in Europe: geographical distribution of Pi types S andZ","volume":"92","author":"Hutchison","year":"1998","journal-title":"Respir Med"},{"key":"10.1053\/rmed.2002.1381_RF5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/ajrccm.160.5.9901055","article-title":"A randomised clinical trial of \u03b11-antitrypsin augmentation therapy","volume":"160","author":"Dirksen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2002.1381_RF6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1183\/09031936.97.10102191","article-title":"Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?","volume":"10","author":"Hutchison","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2002.1381_RF7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.149.3687.986","article-title":"Serum prealbumin: polymorphism in man","volume":"149","author":"Fagerhol","year":"1965","journal-title":"Science"},{"key":"10.1053\/rmed.2002.1381_RF8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1469-1809.1975.tb00611.x","article-title":"The genetics of alpha-1-antitrypsin: a family study in England and Scotland","volume":"38","author":"Cook","year":"1975","journal-title":"Ann Hum Genet"},{"key":"10.1053\/rmed.2002.1381_RF9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000152838","article-title":"Alpha-1-antitrypsin: common subtypes of Pi M","volume":"26","author":"Frants","year":"1976","journal-title":"Hum Hered"},{"key":"10.1053\/rmed.2002.1381_RF10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00287070","article-title":"Report of nomenclature meeting for alpha-1-antitrypsin","volume":"53","author":"Cox","year":"1980","journal-title":"Hum Genet"},{"key":"10.1053\/rmed.2002.1381_RF11","first-page":"775","volume":"1","year":"1965","journal-title":"Lancet"},{"key":"10.1053\/rmed.2002.1381_RF12","first-page":"7","article-title":"Longitudinal studies in alpha-1-antitrypsin deficiency: a survey by the British Thoracic Society","author":"Hutchison","year":"1987"},{"key":"10.1053\/rmed.2002.1381_RF13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2002.1381_RF14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0954-6111(05)80346-4","volume":"88","year":"1994","journal-title":"Respir Med"},{"key":"10.1053\/rmed.2002.1381_RF15","series-title":"SPSS 7.5 Guide to Data Analysis","author":"Norusis","year":"1997"},{"key":"10.1053\/rmed.2002.1381_RF16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/ajrccm\/138.2.327","article-title":"Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms","volume":"138","author":"Brantly","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2002.1381_RF17","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1164\/ajrccm.152.6.8520756","article-title":"Decline in FEV1 among patients with severe hereditary alpha-1-antitrypsin deficiency type PiZ","volume":"152","author":"Seersholm","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2002.1381_RF18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0895-4356(88)90019-4","article-title":"Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ","volume":"41","author":"Wu","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/rmed.2002.1381_RF19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1183\/09031936.99.13224799","article-title":"Decline in FEV1 related to smoking status in individuals with severe \u03b11-antitrypsin deficiency","volume":"13","author":"Piitulainen","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2002.1381_RF20","series-title":"The Natural History of chronic bronchitis and Emphysema","author":"Fletcher","year":"1976"},{"key":"10.1053\/rmed.2002.1381_RF21","first-page":"115","article-title":"The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema","volume":"51","author":"Hughes","year":"1982","journal-title":"Quart J Med"},{"key":"10.1053\/rmed.2002.1381_RF22","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1183\/09031936.97.10102260","article-title":"Does alpha-1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha-1-antitrypsin deficiency?","volume":"10","author":"Seersholm","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2002.1381_RF23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.111.2.394","article-title":"Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency","volume":"111","author":"McElvaney","year":"1997","journal-title":"Chest"},{"key":"10.1053\/rmed.2002.1381_RF24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1164\/ajrccm.156.1.9508014","article-title":"Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency","volume":"156","author":"Eden","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2002.1381_RF25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1183\/09031936.97.10061380","article-title":"Genetic risk factors for chronic obstructive pulmonary disease","volume":"10","author":"Sandford","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2002.1381_RF26","first-page":"S45","article-title":"Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency","volume":"127","author":"Gadek","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/rmed.2002.1381_RF27","first-page":"397","volume":"75","year":"1997","journal-title":"Bull World Health Organization"},{"key":"10.1053\/rmed.2002.1381_RF28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bmj.1.5751.689","article-title":"Pulmonary emphysema and alpha-1-antitrypsin deficiency","volume":"1","author":"Hutchison","year":"1971","journal-title":"Br Med J"},{"key":"10.1053\/rmed.2002.1381_RF29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thx.54.4.287","article-title":"EUROSCOP, ISOLDE and the Copenhagen City Lung study","volume":"54","author":"Burge","year":"1999","journal-title":"Thorax"},{"key":"10.1053\/rmed.2002.1381_RF30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0007-0971(81)90052-8","article-title":"The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema","volume":"75","author":"Bellamy","year":"1981","journal-title":"Br J Dis Chest"},{"key":"10.1053\/rmed.2002.1381_RF31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1164\/ajrccm.161.3.9906011","article-title":"For the Alpha 1-Antitrypsin Deficiency Registry Study Group","volume":"161","author":"Schluchter","year":"2000","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611102913818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611102913818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:03:05Z","timestamp":1760608985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611102913818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0954611102913818"],"URL":"https:\/\/doi.org\/10.1053\/rmed.2002.1381","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/rmed.2002.1381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}